Chula Virtual Open House for 2023 International Graduate Programs

Join us at our Virtual Open House 2023 to learn more about our international graduate programs (Master’s and Doctoral Programs), the admissions process, and the benefits of studying at Chula.

UCI researchers discover crucial role of brain’s striatum cilia in time perception

Irvine, Calif., Nov. 30, 2022 — Researchers at the University of California, Irvine have discovered that removal of cilia from the brain’s striatum region impaired time perception and judgment, revealing possible new therapeutic targets for mental and neurological conditions including schizophrenia, Parkinson’s and Huntington’s diseases, autism spectrum disorder, and Tourette syndrome.

UCI-led study shows Rhodiola rosea root might be beneficial for managing type 2 diabetes

A team of researchers led by the University of California, Irvine has discovered that treatment with an extract from the roots of the Rhodiola rosea plant might be effective for helping manage type 2 diabetes, showing promise as a safe and effective non-pharmaceutical alternative. The study, recently published online in Scientific Reports, found that in a mouse model of human type 2 diabetes, Rhodiola rosea lowered fasting blood sugar levels, improved response to insulin injections, modulated the composition of bacteria in the gastrointestinal tract and decreased several biomarkers of inflammation.

UCI to welcome inaugural Doctor of Pharmacy class at White Coat Ceremony

Irvine, Calif., Sept. 14, 2021 – The inaugural class of Pharm.D. students at the University of California, Irvine will begin their journey Sept. 24 at a White Coat Ceremony, a rite of passage marking the transition from the study of preclinical to clinical health sciences. The white coat is universally recognized as a symbol of the commitment students are making in joining a trusted health profession.

Chula Virtual International Graduate Open House Academic Year 2021-2022

Join us at our Virtual Graduate Open House (International) to find out about the diverse range of international programs available and the benefits of studying at Chula. Organized by the Office of International Affairs and Global Network (OIA), during August 31 – September 3, 2021, at 1.00 – 4.00 PM (GMT +7) via Zoom webinars and Facebook Live, the event is an ideal way to explore the graduate programs, connect with faculty and staff, get answers to your questions about graduate school, and get details on deadlines, funding, career paths, specific requirements, and much more.

Mount Sinai researchers develop novel therapy that could be effective in many cancers

New York, NY (July 23, 2021) — Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery , a…

Llama ‘nanobodies’ could hold key to preventing deadly post-transplant infection

Scientists have developed a ‘nanobody’ – a small fragment of a llama antibody – that is capable of chasing out human cytomegalovirus (HCMV) as it hides away from the immune system. This then enables immune cells to seek out and…

Toward one drug to treat all coronaviruses

Safe and effective vaccines offer hope for an end to the COVID-19 pandemic. However, the possible emergence of vaccine-resistant SARS-CoV-2 variants, as well as novel coronaviruses, make finding treatments that work against all coronaviruses as important as ever. Now, researchers…

Martin Thornhill named 2021 recipient of the IADR Distinguished Scientist Award in PPT

Alexandria, Va., USA – The International Association for Dental Research (IADR) announced Martin Thornhill, University of Sheffield, England, as the 2021 recipient of the IADR Distinguished Scientist Award in Pharmacology/Therapeutics/Toxicology Research. Thornhill was recognized during the Opening Ceremonies of the…

Evidence of sustained benefits of pimavanserin for dementia-related psychosis

Evidence of the sustained benefits of an investigational antipsychotic treatment for people with dementia-related psychosis has been published. Up to half of the 45 million people worldwide who are living with Alzheimer’s disease will experience psychotic episodes, a figure that…

New approach eradicates breast cancer in mice

CHAMPAIGN, Ill. — A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ErSO, quickly shrinks…

New study investigates formation of dangerous compounds by e-cigarettes

Scientists with the Desert Research Institute (DRI) Organic Analytical Laboratory in Reno, Nev., led by Andrey Khlystov, Ph.D., have been awarded a $1.5M grant from the National Institutes of Health (NIH) to study the formation of dangerous compounds by electronic…

Artificial sweeteners enable delivery of carbon monoxide to treat organ injury

ATLANTA–An oral prodrug developed by a team of scientists led by Binghe Wang, Regents’ Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science .…

Measures and clinical approach of COVID 19

The coronavirus disease 2019 (COVID-19) outbreak has spread throughout the globe and much time has passed since it was declared as a pandemic by the World Health Organization (WHO). COVID-19: Diagnosis and Management provides clinicians and scholars all the information…

Present and future application of artificial intelligence in clinical drug

The combination of expert knowledge and multidisciplinary approaches highlighted in the book make it a valuable source of information for physicians and clinical researchers active in the field of cancer diagnosis and treatment (oncologists, oncologic surgeons, radiation oncologists, nuclear medicine…

ISSRDC to feature in-space production applications and its impact on the space economy

KENNEDY SPACE CENTER (FL), July 14, 2021 – The International Space Station Research and Development Conference (ISSRDC) will host multiple sessions focused on in-space production applications during its 10th annual gathering, taking place August 3-5. This year’s event, which will…

Microcrystal electron diffraction supports a new drug development pipeline

CAMBRIDGE July 13, 2021 – To date, solving structures of potential therapeutics using X-ray diffraction (XRD) has been an assumed, pivotal step in the drug development process. But a recent paper by a team of researchers led by NanoImaging Services…

Study Sheds Light on Mechanism of Liposome Accumulation in Tumors

Dmitri Simberg, PhD, associate professor in the University of Colorado Skaggs School of Pharmacy, released a new study of the effectiveness of different types of fluorescent labels used to monitor the accumulation of liposomes in tumors. The study was published on July 1, 2021, in ACS Nano.

Hybrid enzyme catalysts synthesized by a de novo approach for expanding biocatalysis

The two major challenges in industrial enzymatic catalysis are the limited number of chemical reaction types that are catalyzed by enzymes and the instability of enzymes under harsh conditions in industrial catalysis. Expanding enzyme catalysis to a larger substrate scope…

Harnessing AI to discover new drugs

Nature has a vast store of medicinal substances. “Over 50 percent of all drugs today are inspired by nature,” says Gisbert Schneider, Professor of Computer-Assisted Drug Design at ETH Zurich. Nevertheless, he is convinced that we have tapped only a…

Do heart medications affect COVID-19 outcomes?

Cardiovascular drugs do not affect COVID-19 outcomes–such as disease severity, hospitalizations, or deaths–according to an analysis of all relevant studies published as of November 2020. The findings are published in the British Journal of Clinical Pharmacology . Investigators included 429…